InfuSystem Holdings/INFU

$7.90

-1.74%
-
1D1W1MYTD1YMAX

About InfuSystem Holdings

InfuSystem Holdings, Inc. is a health care service provider that facilitates outpatient care for durable medical equipment manufacturers and health care providers. The Company’s segments include Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). The Company’s core service within its ITS segment is its Oncology Business. The ITS segment supplies electronic ambulatory infusion pumps and associated disposable supply kits to private oncology clinics, infusion clinics and hospital outpatient oncology clinics to be utilized in the treatment of a variety of cancers, including colorectal cancer and other disease states. Its DME Services segments core service is to sell or rent new and pre-owned pole-mounted and ambulatory infusion pumps and other Durable Medical Equipment; sell treatment-related consumables; and provide biomedical recertification, maintenance and repair services for oncology practices as well as other healthcare site settings.

Ticker

INFU

Sector

Healthcare

Trading on

AMEX

Industry

Medical Equipment & Supplies

CEO

Richard Diiorio

Employees

499

Headquarters

Rochester hills, United States

INFU Metrics

BasicAdvanced
$170.97M
Market cap
202.88
P/E ratio
$0.04
EPS
1.28
Beta
-
Dividend rate
$170.97M
1.27717
$11.44
$7.87
44.98K
1.949
1.541
55.64
55.64
86.473
1.88%
0.86%
1.74%
1.01%
202.877
1.359
3.258
4.155
1,612.907
14.44%
5,180.77%
8.9%
-63.04%

What the Analysts think about INFU

Analyst Ratings

Majority rating from 3 analysts.
Buy

Price Targets

Average projection from 3 analysts.
87.72% upside
High $17.00
Low $12.50
$7.90
Current price
$14.83
Average price target

INFU Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
0% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$31.7M
-0.63%
Net income
$0
-100%
Profit margin
0%
-100%

INFU Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 20%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
-$0.02
$0.02
$0.03
-
-
Expected
$0.02
$0.00
$0.03
$0.00
$0.02
Surprise
-200%
500.06%
20%
-
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for InfuSystem Holdings stock?

InfuSystem Holdings (INFU) has a market cap of $170.97M as of April 16, 2024.

What is the P/E ratio for InfuSystem Holdings stock?

The price to earnings (P/E) ratio for InfuSystem Holdings (INFU) stock is 202.88 as of April 16, 2024.

Does InfuSystem Holdings stock pay dividends?

No, InfuSystem Holdings (INFU) stock does not pay dividends to its shareholders as of April 16, 2024.

When is the next InfuSystem Holdings dividend payment date?

InfuSystem Holdings (INFU) stock does not pay dividends to its shareholders.

What is the beta indicator for InfuSystem Holdings?

InfuSystem Holdings (INFU) has a beta rating of 1.28. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

What is the InfuSystem Holdings stock price target?

The target price for InfuSystem Holdings (INFU) stock is $14.83, which is 87.72% above the current price of $7.9. This is an average based on projections from 3 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell InfuSystem Holdings stock

Buy or sell InfuSystem Holdings stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing